title: [The past and the present of cardiac glycosides. III. Pharmacokinetics].
abstract: The molecular structure is one of the keypoints that govern both the extent of extracardiac action of cardiac glycosides and their different kinetics. The apolar, fat soluble digitoxin is very well absorbed from the intestine, its onset of action is slow, binds to a high degree to albumin and undergoes enterohepatic recirculation which accounts for a long elimination half time and stability of plasmatic levels. Digitoxin is largely excreted via gastrointestinal tract. The absorption of digoxin is less reliable, onset of action occurs earlier and the binding to albumin is considerably less than that of digitoxin. The drawback, however small, of digoxin lies in a lower stability of plasma levels and prevailing renal excretion. The molecule of strophatin is highly polar, its absorption from the intestine negligible and can be administered only intravenously. The onset of action is prompt, elimination half time short and about half the injected amount is excreted extrarenally.
authors.affiliation: Institutu pro dalsí vzdĕlávání lékarů a farmaceutů, Praha.
authors.forename: P
authors.initials: P
authors.lastname: Synek
mesh_terms: D002301:Cardiac Glycosides / Q000493:pharmacokinetics*; D004074:Digitoxin / Q000493:pharmacokinetics; D004077:Digoxin / Q000493:pharmacokinetics; D005767:Gastrointestinal Diseases / Q000378:metabolism; D006801:Humans; D007674:Kidney Diseases / Q000378:metabolism; D013328:Strophanthins / Q000493:pharmacokinetics; D013959:Thyroid Diseases / Q000378:metabolism
chemical_list: D002301:Cardiac Glycosides; D013328:Strophanthins; D004077:Digoxin; D004074:Digitoxin